Cargando…
Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population
Type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic pathologies in the world. In developing countries, such as Mexico, its prevalence represents an important public health and research issue. Determining factors triggering T2DM are environmental and genetic. While diet, exercise and...
Autores principales: | Rodríguez-Rivera, Nidia Samara, Cuautle-Rodríguez, Patricia, Castillo-Nájera, Fernando, Molina-Guarneros, Juan Arcadio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492814/ https://www.ncbi.nlm.nih.gov/pubmed/28685055 http://dx.doi.org/10.3892/br.2017.921 |
Ejemplares similares
-
Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin
por: Cuautle-Rodríguez, Patricia, et al.
Publicado: (2019) -
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients
por: Ortega-Ayala, Adiel, et al.
Publicado: (2022) -
Tamoxifen side effects: pharmacogenetic and clinical approach in Mexican mestizos
por: Rangel-Méndez, Jorge-Aarón, et al.
Publicado: (2019) -
Frequent copy number variants in a cohort of Mexican-Mestizo individuals
por: Sánchez, Silvia, et al.
Publicado: (2023) -
Genetic Epidemiology of Type 2 Diabetes in Mexican Mestizos
por: García-Chapa, Eiralí Guadalupe, et al.
Publicado: (2017)